FAKTOR-OPTIONSSCHEIN - BICO GROUP B Stock

Certificat

DE000ME0UCS5

Real-time Bid/Ask 07:08:26 2024-05-29 EDT
10.99 EUR / 11.31 EUR -6.14% Intraday chart for FAKTOR-OPTIONSSCHEIN - BICO GROUP B
Current month-7.48%
1 month-0.34%
Date Price Change
24-05-29 10.92 -8.08%
24-05-28 11.88 -3.88%
24-05-27 12.36 +14.13%
24-05-24 10.83 +1.31%
24-05-23 10.69 -0.28%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 06:24 am

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying BICO GROUP AB
Issuer Morgan Stanley
WKN ME0UCS
ISINDE000ME0UCS5
Date issued 2023-09-19
Strike 22.77 kr
Maturity Unlimited
Parity 0.17 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 37.73
Lowest since issue 4.92
Spread 0.32
Spread %2.83%

Company Profile

BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Sector
-
More about the company

Ratings for BICO Group AB

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: BICO Group AB

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
45.54 SEK
Average target price
132.5 SEK
Spread / Average Target
+190.95%
Consensus